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To achieve pain control after arthroscopic shoulder
surgery, nonsteroidal anti-inflammatory drugs (NSAIDs)
are a complement to other analgesics. However, experi-
mental studies have raised concerns that these drugs may
have a detrimental effect on soft tissue-to-bone healing
and, thus, have a negative effect on the outcome. We
wanted to investigate if there are any differences in the
clinical outcome after the arthroscopic Bankart proce-
dure for patients who received NSAIDs prescription com-
pared with those who did not. 477 patients with a primary
arthroscopic Bankart procedure were identified in the
Norwegian shoulder instability register and included in
the study. 32.5% received prescription of NSAIDs post-
operatively. 370 (78%) of the patients answered a
follow-up questionnaire containing the Western Ontario
Shoulder Instability index (WOSI). Mean follow-up was
21 months. WOSI at follow-up were 75% in the NSAID
group and 74% in the control group. 12% of the patients
in the NSAID group and 14% in the control group
reported recurrence of instability. The reoperation rate
was 5% in both groups. There were no statistically sig-
nificant differences between the groups. Prescription of
short-term post-operative NSAID treatment in the post-
operative period did not influence on the functional
outcome after arthroscopic Bankart procedures.
Shoulder instability is a common problem, with an
overall incidence of acute glenohumeral dislocation in
the general population reported from 11 to 56 per
100 000 person-years in different countries (Liavaag
et al., 2011). The peak incidence occurs during the third
decade of life, with a male dominance (Zacchilli &
Owens, 2010) and anterior instability as the predominant
direction (Owens et al., 2007). Young age predicts a high
risk of recurrence and 67% of the patients below 35
years of age develop chronic instability, with new dislo-
cations within 5 years of the primary dislocation
(Robinson, 2006). With an annual incidence of shoulder
stabilization procedures of 12 per 100 000 inhabitants in
Norway (Blomquist et al., 2012) it is estimated that
about one fourth of the patients in Norway with a trau-
matic dislocation end up with a surgical procedure to
stabilize the shoulder joint, with a much higher propor-
tion in the young patients.
The arthroscopic Bankart procedure is widely used in
the treatment of recurrent anterior shoulder instability
(Owens et al., 2011). Although a minimal invasive pro-
cedure, post-operative pain control after shoulder
surgery can be difficult to achieve, even with the use of
an interscalene nerve block (Fredrickson et al., 2010).
Nonsteroidal anti-inflammatory drugs (NSAIDs) have
been proven effective against post-orthopedic surgery
pain (Heidrich et al., 1985; Alexander et al., 2002;
Silvanto et al., 2002; Malan et al., 2003; Axelsson et al.,
2008), but experimental studies in animal models have
raised concerns that these drugs may have a negative
effect on tendon and tendon-to-bone healing in the early
proliferative phase (Dimmen et al., 2009a,b; Chen &
Dragoo, 2012). NSAIDs have an inhibitory effect on
fracture healing in animal studies (Bo et al., 1976) and
have been shown to affect the clinical outcome of long
bone fractures (Burd et al., 2003) and spinal fusion (Li
et al., 2011). However, we have not found any studies
that investigate the effects of NSAIDs on the clinical
outcome after arthroscopic Bankart repair or other pro-
cedures that involve healing between soft tissue and
bone in humans.
On this background, we wanted to investigate if there
are any differences in the clinical outcome for patients
that received NSAIDs in the post-operative phase com-
pared with those who did not.
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Materials and methods
The present study was based on the Norwegian shoulder instability
register (Blomquist et al., 2012) that was established in 2008. The
register includes 54% of the patients who had surgery for glenohu-
meral instability in Norway 1 year after start-up. The surgeon
completed a form at the time of surgery specifying the type of
surgical procedure, any previous surgery and shoulder history,
including duration of symptoms, number of dislocations and the
peroperative bone and soft tissue conditions. If NSAID was pre-
scribed for post-operative administration, medicament name and
duration of treatment was recorded. The patient completed a ques-
tionnaire with the Western Ontario Shoulder Instability Index
(WOSI; Kirkley et al., 1998) pre-operatively. A questionnaire
including the same items was answered by mail 1 and 2 years
post-operatively. In addition, the patients were asked if they had
experienced instability events or had been treated operatively for
instability in the same shoulder after the primary operation. Revi-
sion surgery was linked to the original procedure in the register by
the patient’s social security number. The WOSI score is a disease-
specific, quality of life measurement tool for patients with shoulder
instability. It is built up of 21 visual analog scales in four domains,
reflecting physical symptoms, disability in sport/recreation/work
and impact on lifestyle and emotions. The score is presented either
as an absolute number, ranging from 0 (best) to 2100 (worst), or as
a percentage score were 100% represent the best possible result.
The instrument is validated in several languages, including Norwe-
gian, and is found to have a high validity, reliability, and respon-
siveness for shoulder instability patients. (Skare et al., 2013)A10.4
percentage point difference in WOSI score is considered to reflect a
clinically relevant difference in shoulder function, both for the
individual patient over time and for comparison between groups.
(Kirkley et al., 1998, 2005)
525 patients who underwent an arthroscopic Bankart procedure
during the period from February 2008 to August 2011, without
prior surgery in the same shoulder, were identified in the register
and assessed for eligibility. Twenty-four patients that had no data
on NSAID administration and 24 patients without both pre- and
post-operative WOSI score were excluded from further analysis.
Of the 477 included patients, 463 (97%) had completed the pre-
operative questionnaire. 348 (73%) answered the 1-year follow-up
questionnaire and 283 (59%) answered at 2 years post-operatively.
370 patients (78%) responded at either 1 or 2 years post-
operatively and the last response was carried forward with a mean
follow-up of 21.2 months. Dropout analysis were performed to
evaluate if there were any systematic differences between the
responders and the nonresponders.
322 (68%) of the patient did not receive NSAID in the post-
operative period and was applied as control group. 78 (16%) had
NSAID prescribed for 1–3 days, 63 (13%) for 4–7 days and 14 (3%)
for more than 7 days. All patients treated with NSAIDs post-
operatively were pooled in one group for the statistical analysis.
WOSI score and recurrence rate were both considered to be
adequate as outcome variables that would reflect a true change in
shoulder function. The statistical power to detect a 10.4 percentage
point difference in WOSI score was calculated to be 99%, based
on a significance level at 0.05 and a sample size of 200 and 100 in
the respective groups. However, rate of recurrence was rejected as
primary outcome variable, as the statistical power was low, esti-
mated to 0.26, calculation based on sample size of 200 and 100, a
50% increase in recurrence rate from 10% to 15% and a signifi-
cance level at 0.05.
The primary outcome variable was absolute WOSI score at
follow-up. The null hypothesis was that there is no difference in
outcome between the group treated with NSAIDs post-operatively
and the control group. We also evaluated change in shoulder func-
tion compared with baseline, recurrence rate and reoperation rate
for both groups. Possible confounders such as differences in base-
line WOSI score, age at surgery, traumatic debut, duration of
symptoms, number of dislocations, number of suture anchors
used, post-operative immobilization, ambulatory or in-house
surgery, duration of surgery and follow-up time were analyzed.
Statistics
Descriptive statistics were presented as mean values for normal
distributed continuous variables, median for variables with a
skewed distribution and ratios for categorical variables. t-tests
were used to test differences in mean values and were presented
with 95% confidence interval (CI), Kruskal–Wallis test for com-
parison of medians and chi-square test for categorical variables.
Adjustments were done for possible confounding variables with
uneven distribution in the two groups using univariate analysis of
variance. SPSS Statistics 20 (IBM, New York, USA) software was
used for the statistical evaluation.
Ethics
The study was evaluated by the local ethics committee and con-
sidered not to need an ethical approval. The data collection was
authorized by the Norwegian Data Protection Authority.
Results
The mean age of the included patients was 28.8 years,
ranging from 12 to 74 years. The patients in the NSAID
group were significantly younger, had a shorter duration
of symptoms and were more likely to be treated ambu-
latory (Table 1).
Table 1. Baseline characteristic of patients having a primary arthroscopic Bankart procedure divided by those receiving NSAIDs and the control group (not
receiving NSAIDs)
Baseline characteristic NSAID Control group P-value
n % Mean (95% CI) Median (range) n % Mean (95% CI) Median (range)
WOSI% 125 51 (48–54) 231 52 (49–54) 0.63
Sex, male 127 66 243 68 0.79
Age at surgery 127 24 (58) 243 27 (62) 0.04
Trauma at first dislocation 125 92 236 90 0.50
Symptom duration (months) 116 28 (387) 218 37 (489) 0.02
Patients with > 5 dislocations 122 36 234 36 0.98
Number of suture anchors 118 2.6 (2.5–2.8) 228 2.6 (2.5–2.8) 0.90
Duration of surgery (minutes) 124 70 (64–75) 236 76 (72–79) 0.08
Ambulatory surgery 124 68 240 30 < 0.01
Weeks of immobilization 123 4.7 (4.4–5.0) 225 4.5 (4.3–4.7) 0.16
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Patients treated with NSAIDs post-operatively had an
unadjusted mean WOSI score at follow-up of 75%,
compared with 74% for the control group. Recurrence
rate was 12% in the NSAID and 14% in the control group,
while reoperation rates were 5% in both groups. None of
these differences were statistically significant. Age corre-
lated with symptom duration with a P-value < 0.001 and
the outcome score were therefore only adjusted for age
and ambulatory surgery. The adjusted WOSI score at
follow-up was 74% for the NSAID group and 71% for the
control group, the difference between the groups were
statistically nonsignificant (Table 2).
The increase in WOSI score from baseline to
follow-up was 24 percentage points (95% CI 20.2–28.1,
P < 0.001), from 51% to 75% for the NSAID group. The
control group had an improvement of 22 percentage
points (95% CI 18.9–24.7, P < 0.001), from 52% at
baseline to 74% at follow-up. The difference between the
groups was not statistically significant.
18% of the patients in the NSAID group and 25% of
the patients in the control group did not answer the
follow-up questionnaire. Males were overrepresented
among the nonresponders, however evenly distributed
between the two treatment groups. No other significant
differences were found compared with the patients that
answered the follow-up questionnaire (Table 3). None
of the participating hospitals had an outcome that dif-
fered statistical significant from the mean.
Discussion
We found no effect of NSAIDs on the outcome after an
arthroscopic Bankart procedure. This is in accordance
with previously published articles where there is insuf-
ficient evidence of a detrimental effect on tissue healing,
when using either NSAIDs or COX-2 inhibitors at stan-
dard doses for less than 2 weeks (Chen & Dragoo, 2012).
Anti-inflammatory drugs were prescribed to only one
third of the patients included in the study despite docu-
mented effect on post-operative pain as part of a
multimodal pain therapy (Marret et al., 2005). Although
other side effects, mainly gastrointestinal (Thiéfin et al.,
2010), may account for some restraint, the risk of affect-
ing the long-term surgical result is probably the main
reason for the limited use in this young patient popula-
tion with supposedly few concomitant diseases. The use
of NSAIDs for the treatment of post-operative pain is
controversial for procedures involving healing between
bone and tendon as it is shown that NSAIDs and COX2-
inhibitors affect the tendon-to-bone healing in experi-
mental animal models (Cohen et al., 2006; Dimmen
et al., 2009b). Healing of labral lesions involve an
inflammatory response (Abe et al., 2012) and could
theoretically be inhibited by anti-inflammatory drugs,
but there are no published data that support the theory
that treatment with short-term NSAID in therapeutic
doses has a negative effect on the outcome after
Table 2. Post-operative evaluation of patients having a primary arthroscopic Bankart procedure by those receiving NSAIDs and the control group (not
receiving NSAIDs)
NSAID Control group P-value
n % Mean (95% CI) n % Mean (95% CI)
WOSI% at last follow-up 127 75 (72–78) 243 74 (71–77) 0.60
Adjusted* WOSI% at last follow-up 127 74 (70–78) 243 71 (68–75) 0.27
1-year WOSI% 119 76 (73–79) 229 74 (71–77) 0.42
2-year WOSI% 98 76 (72–79) 185 75 (72–78) 0.77
Recurrence rate at last follow-up 127 12 243 14 0.56
Reoperation rate at last follow-up 127 5 243 5 0.80
*Adjusted for age and ambulatory surgery.
Table 3. Nonresponder’s analysis of baseline characteristics among patients that underwent a primary arthroscopic Bankart procedure
Baseline characteristic Responders Nonresponders P-value
n % Mean (95% CI) Median (range) n % Mean (95% CI) Median (range)
WOSI% 356 52 (50–53) 107 50 (46–53) 0.32
Sex, male 370 67 107 84 < 0.01
Age at surgery 370 27 (62) 107 25 (47) 0.13
Trauma at first dislocation 361 91 107 88 0.41
Symptom duration (months) 334 32 (489) 99 32 (322) 0.94
Patients with > 5 dislocations 356 36 104 43 0.18
Number of suture anchors 346 2.6 (2.5–2.7) 104 2.7 (2.5–2.9) 0.58
Duration of surgery (minutes) 360 74 (71–77) 106 74 (68–79) 0.97
Ambulatory surgery 364 43 106 47 0.46
Weeks of immobilization 348 4.6 (4.4–4.7) 103 4.5 (4.2–4.8) 0.71
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arthroscopic shoulder surgery. It has been found in
earlier clinical studies (Li et al., 2011) that any negative
effect of NSAIDs on healing is dose-dependent. A major-
ity of the patients in this study had NSAIDs prescribed
for 7 days or less. A longer administration of anti-
inflammatory drugs may have a clinical effect not inves-
tigated in the present study. Our data on NSAID use is
obtained from the surgeons planned prescription at the
time of surgery. We have no control on patient compli-
ance and one must assume occurrence of crossover
between the groups during the post-operative period, not
accounted for in the study. This would dilute a potential
effect of NSAID on the outcome. The study is well
powered to detect changes in WOSI score and can tol-
erate a moderate amount of crossover, but the lack of
compliance monitoring is a weakness.
The WOSI score is a well-established instrument to
evaluate outcome after shoulder instability surgery. It is
considered to reflect the change in the patients subjective
shoulder function and quality of life and the groups have
a very similar functional outcome. This was a prospective
cohort study with participants from hospitals in all parts
of Norway and we can anticipate that the sample popula-
tion is representative for the general population who
needs instability surgery and should therefore be valid for
this group of patients. The groups differed in age, with a
significantly lower age and a higher proportion of patients
below 20 years in the NSAID group. Young age is found
to be a risk factor for inferior outcome after arthroscopic
stabilization (Boileau et al., 2006) and adjustment for age
further strengthen the finding that NSAIDs have no nega-
tive influence on the outcome.
The study is underpowered to detect an increase in
recurrence rate and one might therefore argue that a
moderate increased recurrence rate cannot be ruled out,
even though we found a slightly lower recurrence rate at
2 years in the NSAID group. Studies have shown a linear
recurrence incidence over time after arthroscopic
Bankart procedures (Castagna et al., 2010), and a weak-
ened bone-labrum interface due to post-operative
NSAID administration could theoretical affect the recur-
rence rate several years after the surgery. Long follow-up
and a large patient population are needed to answer this
question. An arthro-CT evaluation of the joint could
assess attachment of labrum to bone after a certain post-
operative time interval. It is however difficult to draw
conclusions regarding risk of recurrence based on
healing on MRI or CT, as studies have shown that
Bankart lesion could be radiological well adapted, but
without correlation with recurrence rate (Liavaag et al.,
2009; Liavaag, 2011). Post-operative arthroCT also raise
ethical questions and was not part of this register study.
The lack of randomization is a weakness to the study.
The use of NSAIDs or not is usually consistent for each
participating surgeon and there could be a performance
bias between the groups that could mask an effect of
NSAID administration. The finding that NSAIDs are
more commonly used in ambulatory surgery might
imply a higher experience level for the surgeons in this
group. Based on knowledge of the participating hospitals
and the national funding structure for health care, we see
that the use of in-house or ambulatory surgery to a large
extent is based on local routines and facilities and is
more prone to follow hospital and region than the
surgeon. We believe that the more extent use of NSAIDs
for ambulatory patients reflects the need for proper pain
control without the facilities for inter-scalene block or
parenteral analgesics, but we have no information on
this. The high number of participating hospitals would
normally dilute a surgeon effect and none of the partici-
pating hospitals have a statistical significant below par
outcome that would affect the result.
Perspectives
To achieve adequate and predictable pain control after
shoulder surgery, a multimodal approach is normally used,
where inter-scalene nerve block, opioid analgesics, and
NSAIDs are the main components (Fredrickson et al.,
2010). Single-injection inter-scalene block gives excellent
immediate pain control, but because of its short and unpre-
dictable duration, there is a high risk that the patient expe-
rience severe and uncontrollable pain the first night after
surgery (Boezaart & Tighe, 2010). Continuous nerve block
gives a better pain control but is more technically and
logistically demanding (Boezaart, 2002). As the severity
and duration of pain after shoulder surgery has a high
inter-individual variation, it is challenging to safely admin-
ister an adequate dosage of opiate analgesics, especially
after single-injection inter-scalene block and for ambula-
tory patients without professional post-operative monitor-
ing. It is our experience that NSAIDs, in combination with
other modalities, is a very valuable component to achieve
post-operative pain control. In this registry study, we found
that only one third of the patients received anti-
inflammatory drugs in the post-operative phase and less
than half were treated ambulatory. A randomized study
would be the best tool to test if there is a difference in
outcome between the group treated with NSAIDs post-
operatively and the control group. So far, this cohort study
support the view that short-term NSAIDs in moderate
dosages can be safely administered after arthroscopic
Bankart repair, without any affect on the outcome.
Key words: Shoulder surgery, shoulder instability,
arthroscopic Bankart, nonsteroidal anti-inflammatory
drugs, NSAID.
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